Key facts
- This page summarizes Matthew R. Kane's Form 4 filing for PRECISION BIOSCIENCES INC (DTIL).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 May 2021, 16:50.
Matthew R. Kane - 13 May 2021 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- DTIL
- Reported as of
- 13 May 2021
- Net transaction value
- -$85,827
- SEC form
- 4
- Accepted by SEC
- 14 May 2021, 16:50:27 UTC
- Prior SEC filing
- 11 May 2021
- Next SEC filing
- 09 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew R. Kane
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Matthew R. Kane filed Form 4 for PRECISION BIOSCIENCES INC (DTIL) on 14 May 2021.
Change
- Previous filing in this sequence was filed on 11 May 2021.
- Current net transaction value: -$85,827.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DTIL
transaction
Common Stock
Options Exercise
- Transaction value
- $861
- Shares
- +21,514
- Change %
- +1.1%
- Price
- $0.0400*
- Shares after
- 2,023,272
- Date
- 13 May 2021
- Ownership
- Direct
DTIL
transaction
Common Stock
Sale
- Transaction value
- $86,688
- Shares
- -9,675
- Change %
- -0.48%
- Price
- $8.96
- Shares after
- 2,013,597
- Date
- 13 May 2021
- Ownership
- Direct
- Footnotes
- F1, F2
DTIL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,841
- Date
- 13 May 2021
- Ownership
- By Spouse
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DTIL
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -21,514
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 13 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,514
- Exercise price
- $0.0400
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.96 to $9.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
Shares are held by Chelsea Lynam Kane, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Footnote F4
The option is fully vested and exercisable.